What We're Reading: Page 168
Industry reads hand-picked by our editors
Mar 30, 2021
-
The Atlantic
A Terrible Conundrum for the AstraZeneca Vaccine
-
Endpoints News
After dismissing CFO over ‘inappropriate messages,’ Eli Lilly faces new accusations of sexual harassment
-
Axios
The growing fight over coronavirus vaccine patents
-
Reuters
Amarin's heart drug Vazkepa gets European Commission approval
Mar 29, 2021
-
ProPublica
Inside Purdue Pharma's Media Playbook: How It Planted the Opioid 'Anti-Story'
-
Science
A rare clotting disorder may cloud the world's hopes for AstraZeneca's COVID-19 vaccine
-
The Boston Globe
At Mass General Brigham, a sweeping effort to unify hospitals and shed old rivalries
-
CNBC
White House weighs temporarily lifting intellectual property shield on Covid-19 vaccines
-
Evaluate Vantage
Humanigen claims a Covid-19 win with lenzilumab
Mar 26, 2021
-
Bloomberg
Merck's Little Brown Pill Could Transform the Fight Against COVID
-
Fierce Pharma
Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay
-
The New York Times
Executive With Ties to Cuomo Got Special Access to Virus Testing
-
Endpoints News
Two Church lab vets, a secretive institute and an Israeli billionaire hunt for drugs in the guts of wild animals
Mar 25, 2021
-
The Washington Post
NIH Moderna vaccine patent should be used to expand global access, advocates say
-
Evaluate Vantage
Big pharma's key catalysts in the second quarter
-
STAT
Companies helping big Covid-19 vaccine makers are getting rich
-
FiercePharma
Novartis is shutting down Colorado plant, laying off 400 employees after overestimating gene therapy demand
Mar 24, 2021
-
The Wall Street Journal
How a Promising Covid-19 Vaccine Lost Its Way—And Found It Again
-
Reuters
Merck names Caroline Litchfield as new CFO
-
POLITICO
Drugmakers prepare for the unusual: A defeat in Washington
-
Boston Business Journal
Gilead virology drug chief Diana Brainard takes CEO post at AlloVir
Mar 23, 2021
-
STAT
Amy Abernethy, deputy commissioner who aimed to amp up FDA’s tech knowhow, to leave post
-
CNN
Bernie Sanders making plans to push prescription drug reforms through reconciliation
-
The Wall Street Journal
Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic
-
Reuters
Novartis radioligand therapy improves prostate cancer survival
Mar 22, 2021
-
Science Translational Medicine
AI and Drug Discovery: Attacking the Right Problems
-
The Financial Times
Scramble to make Covid vaccines causes US drug shortages
-
Forbes
AstraZeneca’s Pascal Soriot Was The Hottest CEO In Pharma. Now He’s In The Hot Seat.
-
The Washington Post
Drug companies defend vaccine monopolies in face of global outcry
Previous
